0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 200 200 200 xbrli:pure xbrli:shares iso4217:GBP 07739359 2023-05-01 2024-04-30 07739359 2024-04-30 07739359 2023-04-30 07739359 2022-05-01 2023-04-30 07739359 2023-04-30 07739359 2022-04-30 07739359 bus:Director2 2023-05-01 2024-04-30 07739359 core:WithinOneYear 2024-04-30 07739359 core:WithinOneYear 2023-04-30 07739359 core:ShareCapital 2024-04-30 07739359 core:ShareCapital 2023-04-30 07739359 core:RetainedEarningsAccumulatedLosses 2024-04-30 07739359 core:RetainedEarningsAccumulatedLosses 2023-04-30 07739359 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 07739359 core:Non-currentFinancialInstruments 2024-04-30 07739359 core:Non-currentFinancialInstruments 2023-04-30 07739359 bus:SmallEntities 2023-05-01 2024-04-30 07739359 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 07739359 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 07739359 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 07739359 bus:FullAccounts 2023-05-01 2024-04-30
COMPANY REGISTRATION NUMBER: 07739359
JULIAN GRANT HOLDINGS LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
30 April 2024
JULIAN GRANT HOLDINGS LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2024
CONTENTS
PAGE
Statement of financial position
1
Notes to the financial statements
3
JULIAN GRANT HOLDINGS LIMITED
STATEMENT OF FINANCIAL POSITION
30 April 2024
2024
2023
Note
£
£
FIXED ASSETS
Investments
3
200
200
CURRENT ASSETS
Debtors
4
1,740
1,980
CREDITORS: amounts falling due within one year
5
3,100
3,000
--------
--------
NET CURRENT LIABILITIES
1,360
1,020
--------
--------
TOTAL ASSETS LESS CURRENT LIABILITIES
( 1,160)
( 820)
--------
-----
NET LIABILITIES
( 1,160)
( 820)
--------
-----
JULIAN GRANT HOLDINGS LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
30 April 2024
2024
2023
Note
£
£
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
( 1,260)
( 920)
--------
-----
SHAREHOLDERS DEFICIT
( 1,160)
( 820)
--------
-----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 28 January 2025 , and are signed on behalf of the board by:
Mr S Roe
Director
Company registration number: 07739359
JULIAN GRANT HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2024
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Onega House, 112 Main Road, Sidcup, Kent, DA14 6NE, United Kingdom.
2. ACCOUNTING POLICIES
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
3. INVESTMENTS
Shares in group undertakings
£
Cost
At 1 May 2023 and 30 April 2024
200
-----
Impairment
At 1 May 2023 and 30 April 2024
-----
Carrying amount
At 30 April 2024
200
-----
At 30 April 2023
200
-----
Julian Grant Holdings Limited owns 100% of the issued share capital in Julian Grant Limited, Julian Grant Properties Limited.
Aggregate capital and reserves
2024
2023
£
£
Julian Grant Properties Limited
691,092
684,229
Julian Grant Limited
489,518
492,725
Profit and (loss) for the year
2024
2023
£
£
Julian Grant Properties Ltd
7,296
122,522
Julian Grant Limited
(3,207)
(1,641)
4. DEBTORS
2024
2023
£
£
Other debtors
1,740
1,980
--------
--------
5. CREDITORS: amounts falling due within one year
2024
2023
£
£
Trade creditors
240
240
Amounts owed to group undertakings and undertakings in which the company has a participating interest
2,520
2,520
Corporation tax
100
Other creditors
240
240
--------
--------
3,100
3,000
--------
--------
6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES
At 30 April 2024 the directors owed Julian Grant Holdings Limited £1,740 (2023: £1,980). There are no terms attached to the loan provided to the directors and it has been provided by the company interest free.